Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012 | ||
| dc.conicet.organizacion | Instituto Nacional de Salud | |
| dc.conicet.organizacion | Instituto Nacional de Salud | |
| dc.conicet.organizacion | Instituto Nacional de Salud | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Biotecnología y Biología Molecular. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Biotecnología y Biología Molecular | |
| dc.contributor.author | Bailon, H | |
| dc.contributor.author | León-Janampa, N | |
| dc.contributor.author | Padilla, C. | |
| dc.contributor.author | Hozbor, Daniela Flavia | |
| dc.date.issued | 2016-08 | |
| dc.description.abstract | As has occurred in many regions worldwide, in 2012 the incidence of pertussis increased in Perú. This epidemiologic situation has been associated with a waning vaccine-induced immunity and the adaptation of Bordetella pertussis to vaccine-induced immunity along with improved diagnostic methods. Methods: The study comprised a total of 840 pertussis-suspected cases reported in Perú during 2012. We summarize here the distribution of pertussis cases according to age and immunization status along with the immunization-coverage rate. Laboratory diagnosis was performed by culture test and real-time polymerase-chain reaction (PCR). B. pertussis bacteria recovered from infected patients were characterized by pulsed-field gel electrophoresis (PFGE), and the DNA sequencing of the pertussis-toxin (promoter and subunit A), pertactin, and fimbriae (fim2 and fim3) genes. Results: From the total pertussis-suspected cases, 191 (22.7 %) infections were confirmed by real-time PCR and 18 through cultivation of B. pertussis (2.1 %), while one infection of B. parapertussis (0.11 %) was also detected by culture. Pertussis was significantly higher in patients that had had 0-3 vaccine doses (pentavalent vaccine alone) than in those who had had 4-5 vaccine doses (pentavalent plus DwPT boosters) at 94.3 vs. 5.7 %, respectively (p < 0.00001). The relative risk (RR) for patients with 4-5 doses compared to those with fewer than 4 doses or no dose was 0.23 (95 % Confidence Interval: 0.11-0.44), while the vaccine effectiveness was 77 % and coverage 50.5 %. Genetic analysis of B. pertussis isolates from different Peruvian regions detected two clonal groups as identified by PFGE. Those two groups corresponded to the B. pertussis genotypes emerging worldwide ptxP3-ptxA1-prn2 or 9-fim3-1 and ptxP3-ptxA1-prn2 or 9-fim3-2. Conclusions: Two emerging B. pertussis genotypes similar to isolates involved in worldwide epidemics were detected in Perú. Low vaccine coverage (<50 %) and genetic divergence between the vaccine-producing strain and the local isolates could contribute to this pertussal epidemic. | es |
| dc.description.fil | Fil: Bailon, H. Instituto Nacional de Salud; Perú | |
| dc.description.fil | Fil: León-Janampa, N. Instituto Nacional de Salud; Perú | |
| dc.description.fil | Fil: Padilla, C.. Instituto Nacional de Salud; Perú | |
| dc.description.fil | Fil: Hozbor, Daniela Flavia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Biotecnología y Biología Molecular. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Biotecnología y Biología Molecular; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Bailon, H; León-Janampa, N; Padilla, C.; Hozbor, Daniela Flavia; Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012; BioMed Central; BMC Infectious Diseases; 16; 1; 8-2016; 422-429 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1471-2334 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/100506 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.number | 1 | es |
| dc.journal.pagination | 422-429 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | BMC Infectious Diseases | es |
| dc.journal.volume | 16 | es |
| dc.language.iso | eng | es |
| dc.publisher | BioMed Central | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-016-1700-2 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1186/s12879-016-1700-2 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by/2.5/ar/ | * |
| dc.subject | BORDETELLA PERTUSSIS | es |
| dc.subject | GENOTYPE | es |
| dc.subject | PERTUSSIS | es |
| dc.subject | PERÚ | es |
| dc.subject | PULSED-FIELD GEL ELECTROPHORESIS | es |
| dc.subject.classification | Biología Celular, Microbiología | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012 | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.f9295c8d-d4c4-4bac-bfc2-9e159793bdd0_A.pdf
- Tamaño:
- 1.25 MB
- Formato:
- Adobe Portable Document Format